Acute Myeloid Leukemia

Showing NaN - NaN of 91

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia Trial in Boston (Cytokine-Induced Memory-like Natural Killer

Not yet recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Cytokine-Induced Memory-like Natural Killer Cells
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 22, 2023

Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

Not yet recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Cytokine Induced Memory-like Natural Killer Cells
  • Interleukin-2
  • Boston, Massachusetts
  • +1 more
Nov 14, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +10 more
  • Jacksonville, Florida
  • +5 more
Aug 14, 2023

Acute Myeloid Leukemia, MDS, Myeloid Malignancies Trial in Boston (Decitabine, Filgrastim)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Boston, Massachusetts
  • +1 more
Mar 31, 2023

Acute Myeloid Leukemia, Down Syndrome, Myelodysplastic Syndrome Trial in Worldwide (Asparaginase, Asparaginase Erwinia

Active, not recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Birmingham, Alabama
  • +190 more
Jan 30, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Boston (BXCL701)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome With Excess Blasts-2
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 26, 2023

Acute Leukemias, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Worldwide (JNJ-75276617)

Recruiting
  • Acute Leukemias
  • +2 more
  • Duarte, California
  • +28 more
Jan 27, 2023

Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (Orca-T,

Recruiting
  • Acute Myeloid Leukemia
  • +7 more
  • Orca-T
  • Standard-of-Care
  • Duarte, California
  • +13 more
Jan 25, 2023

Acute Myeloid Leukemia Trial in United States (Standard Leukemia Care, Palliative Care)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Standard Leukemia Care
  • Palliative Care
  • Boston, Massachusetts
  • +3 more
Jan 24, 2023

Acute Myeloid Leukemia Trial in Worldwide (MBG453, Venetoclax, Azacitidine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Birmingham, Alabama
  • +27 more
Jan 20, 2023

Acute Myeloid Leukemia, MDS, Myeloproliferative Tumor Trial in Boston (CIML NK, Fludarabine, Cyclophosphamide)

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • CIML NK
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jan 6, 2023

Acute Myeloid Leukemia Trial in United States (CPX-351, Venetoclax, Midostaurin)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Duarte, California
  • +9 more
Jan 3, 2023

Acute Myeloid Leukemia Trial in United States (Gilteritinib, Midostaurin, Daunorubicin)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Scottsdale, Arizona
  • +43 more
Nov 17, 2022

Acute Myeloid Leukemia Trial in United States (Cytarabine, Idarubicin, Daunorubicin)

Recruiting
  • Acute Myeloid Leukemia
  • Duarte, California
  • +6 more
Nov 16, 2022

Acute Myeloid Leukemia Trial in United States (CPX-351, Venetoclax)

Completed
  • Acute Myeloid Leukemia
  • Duarte, California
  • +7 more
Nov 7, 2022

Acute Myeloid Leukemia, Pediatric Cancer Trial in Boston (Uproleselan, Fludarabine, Clofarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Pediatric Cancer
  • Boston, Massachusetts
  • +1 more
Oct 24, 2022

Acute Myeloid Leukemia Trial in United Kingdom, United States (Arm 1: NTLA-5001, Arm 2: NTLA-5001)

Terminated
  • Acute Myeloid Leukemia
  • Arm 1: NTLA-5001
  • Arm 2: NTLA-5001
  • Los Angeles, California
  • +9 more
Oct 13, 2022

Acute Myeloid Leukemia Trial in Boston, Columbus (Palliative Care, Standard Leukemia care)

Recruiting
  • Acute Myeloid Leukemia
  • Palliative Care
  • Standard Leukemia care
  • Boston, Massachusetts
  • +1 more
Aug 23, 2022

Acute Myeloid Leukemia Trial in United States (Cytarabine, Daunorubicin, Uproleselan)

Suspended
  • Acute Myeloid Leukemia
  • Little Rock, Arkansas
  • +187 more
Aug 17, 2022

AML, Acute Myeloid Leukemia Trial in Boston (DREAMLAND, CERENA)

Not yet recruiting
  • AML
  • Acute Myeloid Leukemia
  • DREAMLAND
  • CERENA
  • Boston, Massachusetts
    Massachusetts General Hospital
Aug 12, 2022

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Baltimore, Boston, Columbus (Enasidenib)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Chronic Myelomonocytic Leukemia
  • Baltimore, Maryland
  • +3 more
Aug 8, 2022

Collecting and Storing Tissue From Young Patients With Cancer

Recruiting
  • Acute Lymphoblastic Leukemia
  • +13 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Birmingham, Alabama
  • +68 more
Aug 4, 2022

Myeloid Malignancy, MDS, Myelofibrosis Trial in Boston (Navitoclax, Venetoclax, Decitabine)

Recruiting
  • Myeloid Malignancy
  • +4 more
  • Boston, Massachusetts
  • +2 more
Jul 21, 2022